Based on the Ambu A/S stock forecast from 0 analysts, the average analyst target price for Ambu A/S is not available over the next 12 months. Ambu A/S’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ambu A/S is Slightly Bearish, which is based on 4 positive signals and 9 negative signals. At the last closing, Ambu A/S’s stock price was EUR 13.95. Ambu A/S’s stock price has changed by +0.25% over the past week, -7.40% over the past month and +1.71% over the last year.
No recent analyst target price found for Ambu A/S
No recent average analyst rating found for Ambu A/S
Company Overview Ambu A/S
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, resuscitators, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark. Read Less
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as broncho...Read More
Frequently Asked Questions About Ambu A/S (547A:F) Stock
Stock Target Advisor's fundamental analysis for Ambu A/S's stock is Slightly Bearish.
547A:F stock's dividend yield is 0.35%.
Our analysis grades 547A:F stock's dividend yield at F. This means that 547A:F stock's dividend yield is above 10% of the stocks in the Medical Devices sector in the F exchange.
Based on this 547A:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 547A:F's stock to indicate what its average analyst target is.
547A:F stock's Price/Earning ratio is 121.63.
Our analysis grades 547A:F stock's Price / Earning ratio at F. This means that 547A:F stock's Price/Earning ratio is above 84% of the stocks in the Medical Devices sector in the F exchange.
Based on this 547A:F may be a overvalued for its sector.
The last closing price of 547A:F's stock was EUR 13.95.
The most recent market capitalization for 547A:F is EUR 3.99B.
Unfortunately we do not have enough analyst data on 547A:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ambu A/S's stock.
As per our most recent records Ambu A/S has 5,196 Employees.
Ambu A/S's registered address is Baltorpbakken 13, Ballerup, Denmark, 2750.
You can get more information about it from Ambu A/S's website at https://www.ambu.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Ambu A/S (547A:F) Stock
Stock Target Advisor's fundamental analysis for Ambu A/S's stock is Slightly Bearish.
547A:F stock's dividend yield is 0.35%.
Our analysis grades 547A:F stock's dividend yield at F. This means that 547A:F stock's dividend yield is above 10% of the stocks in the Medical Devices sector in the F exchange.
Based on this 547A:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 547A:F's stock to indicate what its average analyst target is.
547A:F stock's Price/Earning ratio is 121.63.
Our analysis grades 547A:F stock's Price / Earning ratio at F. This means that 547A:F stock's Price/Earning ratio is above 84% of the stocks in the Medical Devices sector in the F exchange.
Based on this 547A:F may be a overvalued for its sector.
The last closing price of 547A:F's stock was EUR 13.95.
The most recent market capitalization for 547A:F is EUR 3.99B.
Unfortunately we do not have enough analyst data on 547A:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ambu A/S's stock.
As per our most recent records Ambu A/S has 5,196 Employees.
Ambu A/S's registered address is Baltorpbakken 13, Ballerup, Denmark, 2750.
You can get more information about it from Ambu A/S's website at https://www.ambu.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 547A:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
